Search

Search Results
Results 19141 - 19150 of 19770 for Able-bodied
  • Drug - 30 Jul 2025
    Consumer Medicine Information (CMI) about Pavtide intended for persons living in Australia.
  • Drug - 29 Jul 2025
    Consumer Medicine Information (CMI) about Dexmedetomidine Viatris intended for persons living in Australia.
  • Drug - 24 Jul 2025
    Consumer Medicine Information (CMI) about Isentress and Isentress HD intended for persons living in Australia.
  • White Paper - 24 Jul 2025
    Learn how antibody-drug conjugates are advancing therapies for non-cancer conditions, unlocking new possibilities in precision medicine.
  • Drug - 21 Jul 2025
    Consumer Medicine Information (CMI) about Hemlibra intended for persons living in Australia.
  • Drug - 14 Jul 2025
    Consumer Medicine Information (CMI) about Cuvitru intended for persons living in Australia.
  • White Paper - 3 Jul 2025
    Explore how the ratio of pd-1+ treg to ctl and the presence of tertiary lymphoid structures can influence treatment outcomes in advanced gastric cancer.
  • White Paper - 24 Jun 2025
    Learn how in vitro diagnostic (IVD) devices can comply with IVDR and Indian MDR standards, ensuring regulatory alignment, safety, and market readiness.
  • Drug - 26 May 2025
    Consumer Medicine Information (CMI) about Mozobil intended for persons living in Australia.
  • Drug - 22 May 2025
    Consumer Medicine Information (CMI) about Acetec intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.